Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2004
07/15/2004US20040138465 Cyclization process for substituted benzothiazole derivatives
07/15/2004US20040138450 Agriculture salts and oxides
07/15/2004US20040138448 Synthesis of non-symmetrical sulfamides using burgess-type reagents
07/15/2004US20040138286 Rho kinase inhibitors
07/15/2004US20040138284 Indol-3-yl derivatives
07/15/2004US20040138283 Deep vein thrombosis, noninsulin dependent diabetes, atherosclerosis, and pulmonary fibrosis treatment; cardiovascular and brain disorders
07/15/2004US20040138276 Metalloproteinase inhibitors
07/15/2004US20040138271 Benzene compound and salt thereof
07/15/2004US20040138268 Aminoalkyl thiazole derivatives as KCNQ modulators
07/15/2004US20040138259 Pain management
07/15/2004US20040138254 Central nervous system disorders; analgesics; headaches
07/15/2004US20040138232 Psychological disorders; acylation the corresponding indol-2-one form with acylation agent
07/15/2004US20040138230 Psychological and central nervous system disorders; alzheimer's disease; Huntington's disease
07/15/2004US20040138229 Platelet adenosine diphosphate receptor antagonists
07/15/2004US20040138227 Antiserotonine agents; antidepressants
07/15/2004US20040138223 Novel amide derivatives and medicinal use thereof ugs
07/15/2004US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics
07/15/2004US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/15/2004US20040138213 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
07/15/2004US20040138205 Viricides; hepatitis virus
07/15/2004US20040138203 Antiserotonine agents
07/15/2004US20040138199 Antiinflammatory agents; cardiovascular disorders; anticancer agents
07/15/2004US20040134387 obtained from plant by-products or waste suspended through wet-grinding and suspended by means of a microballs mill; includes silica fume, fly ashes, heavy ashes, slags or stone sludge, in form of pellets, sludge or blocks
07/15/2004DE10300099A1 Indol-Phenylsulfonamid-Derivate Indole derivatives phenylsulfonamide
07/15/2004DE10300017A1 Selektive MMP 13 Inhibitoren Selective MMP inhibitors 13
07/15/2004DE10300015A1 Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen Iminosäurederivate as inhibitors of matrix metalloproteinases
07/15/2004CA2512099A1 New pyridazin-3(2h)-one derivatives
07/15/2004CA2511603A1 4, 5-diarylthiazole derivatives as cb-1 ligands
07/15/2004CA2511506A1 Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors
07/15/2004CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions
07/15/2004CA2511235A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
07/15/2004CA2510084A1 Thiazole compounds as integrin receptor antagonists derivatives
07/15/2004CA2508921A1 Quinazoline compounds
07/15/2004CA2485429A1 Thiadiazoles or oxadiazoles and their use as inhibitors of jak protein kinase
07/14/2004EP1437349A1 Substituted isoxazoles and the use thereof as antibiotics
07/14/2004EP1436289A2 Heteroaryl substituted benzothiazole dioxetanes
07/14/2004EP1436287A2 Small organic molecule regulators of cell proliferation
07/14/2004EP1436270A1 Novel benzothiazine derivatives, their preparation and use
07/14/2004EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
07/14/2004EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase
07/14/2004EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications
07/14/2004EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
07/14/2004EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity
07/14/2004EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors
07/14/2004EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes
07/14/2004EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435785A1 Iminobenzoxazines, iminobenzothiazines and iminoquinazolines for controlling invertebrate pests
07/14/2004EP1365760A4 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
07/14/2004EP1235803B1 Urea compounds having muscarinic receptor antagonist activity
07/14/2004EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
07/14/2004EP1204323B1 Fungicides
07/14/2004CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer
07/14/2004CN1513171A Optical data carrier containing dye in the information layer as light-absorbing compound
07/14/2004CN1512991A 吡咯烷双环化合物 Pyrrolidine bicyclic compound
07/14/2004CN1512983A Compounds and compositions as cathepsins inhibitors
07/14/2004CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents
07/14/2004CN1512874A Novel dyeing composition for dyeing-keratinous fibers comprising particular dicationic diazo dye
07/14/2004CN1511863A Novel organic semiconductor polymer and organic thin film transistor using said polymer
07/14/2004CN1511837A Intermediate for heterocyclic compound in preparing rotamase inhibitor
07/14/2004CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
07/14/2004CN1157380C Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants agents
07/13/2004US6762200 Phospholipase inhibitors
07/13/2004US6762197 Fungicides
07/13/2004US6762196 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
07/13/2004US6762194 Quinolinone derivatives
07/13/2004US6762181 Broad antibacterial activity including drug resistant staphylococcus aureus (mrsa), pneumococcus (prsp) and enterococcus (vre); safely used in conjuction with nonsteroidal antiinflammatory drugs
07/13/2004US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma
07/13/2004US6762175 Fatty acid derivatives
07/13/2004US6761878 Pathological tissue detection and treatment employing targeted benzoindole optical agents
07/13/2004CA2272690C Process for making 2-amino-2-imidazoline, guanidine, and 2-amino-3,4,5,6-tetrahydropyrimidine derivatives
07/08/2004WO2004056832A2 Epothilone derivatives
07/08/2004WO2004056820A1 Benzoxazines and derivatives thereof as inhibitors of pi3ks
07/08/2004WO2004056817A1 Oxazolidinone derivatives and their use as antibacterial agents
07/08/2004WO2004056816A1 Antibacterial oxazolidinones
07/08/2004WO2004056815A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS
07/08/2004WO2004056807A1 Pyrimidine derivatives for the treatment of abnormal cell growth
07/08/2004WO2004056800A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/08/2004WO2004056799A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
07/08/2004WO2004056789A1 Mek inhibiting oxa- and thia-diazol-2-yl phenylamine derivates
07/08/2004WO2004056786A2 Pyrimidine derivates for the treatment of abnormal cell growth
07/08/2004WO2004056785A2 Uracils having a herbicidal activity
07/08/2004WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments
07/08/2004WO2004056782A1 Pyrazole compounds
07/08/2004WO2004056774A2 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
07/08/2004WO2004056772A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists
07/08/2004WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders
07/08/2004WO2004056366A1 Phthalazine derivatives as phosphodiesterase 4 inhibitors
07/08/2004WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
07/08/2004WO2004056364A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
07/08/2004WO2004056347A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
07/08/2004WO2004032882A3 Chemical compounds
07/08/2004WO2004026226A3 Compounds, compositions and methods
07/08/2004WO2004022060A3 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
07/08/2004WO2004014902A3 Compounds having an activity at metabotropic glutamate receptors
07/08/2004WO2004009017A3 Modulators of the glucocorticoid receptor and method
07/08/2004WO2003103663A3 Substituted pyrrolines as kinase inhibitors
07/08/2004US20040133011 Useful for therapy of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome
07/08/2004US20040133008 Amide compounds
07/08/2004US20040132809 Cell adhesion inhibitors